<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Roig-Soriano X</submitter><funding>Generalitat de Catalunya</funding><funding>Fundació Bosch i Gimpera</funding><funding>European Regional Development Fund</funding><pagination>163-176</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12701751</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>59(1)</volume><pubmed_abstract>&lt;h4>Aim&lt;/h4>To characterise and evaluate mucoadhesive strength and antibacterial properties of a nanotechnological formulation for endodontic disinfection based on biodegradable nanoparticles dispersed in a thermosensitive gel containing calcium hydroxide (Ca(OH)&lt;sub>2&lt;/sub>-NPs-gel).&lt;h4>Methodology&lt;/h4>Morphology of Ca(OH)&lt;sub>2&lt;/sub>-NPs-gel was studied using transmission electron microscopy. Moreover, Ca(OH)&lt;sub>2&lt;/sub>-NPs-gel was sterilised using gamma irradiation (25 kGy), and the stability after the sterilisation process was studied by measuring Ca(OH)&lt;sub>2&lt;/sub>-NPs-gel average size, polydispersity index, zeta potential and encapsulation efficiency. To assess the ex vivo mucoadhesive strength, extracted single-rooted human teeth were used to measure the force necessary to separate the formulation from the teeth. In addition, the short-time stability of Ca(OH)&lt;sub>2&lt;/sub>-NPs-gel was evaluated monthly, analysing entrapment efficacy, backscattering and transmittance of Ca(OH)&lt;sub>2&lt;/sub>-NPs-gel stored at different temperatures (4°C, 25°C and 37°C). Furthermore, the antibacterial analysis of Ca(OH)&lt;sub>2&lt;/sub>-NPs-gel was performed against Enterococcus faecalis inoculated in extracted human single-root teeth and evaluated by confocal and scanning electron microscopy. Finally, the metabolic activity of bacteria was studied through a resazurin assay to evaluate bacterial survival after treatment.&lt;h4>Results&lt;/h4>Ca(OH)&lt;sub>2&lt;/sub>-NPs-gel owned a round shape and a smooth surface without particle aggregation. Sterilisation did not induce an alteration in Ca(OH)&lt;sub>2&lt;/sub>-NPs-gel physicochemical properties and Ca(OH)&lt;sub>2&lt;/sub>-NPs-gel presented a high adhesion strength. In addition, 4°C was the best temperature to store Ca(OH)&lt;sub>2&lt;/sub>-NPs-gel. Regarding the antibacterial therapeutic efficacy, Ca(OH)&lt;sub>2&lt;/sub>-NPs-gel possesses suitable antibacterial properties, indicating that it efficiently reduces bacterial biofilms.&lt;h4>Conclusion&lt;/h4>Calcium hydroxide-loaded PLGA nanoparticles dispersed in a thermosensitive gel have been developed, optimised and characterised, obtaining excellent antibacterial properties and achieving bacterial disinfection levels similar to those of commercial formulations.</pubmed_abstract><journal>International endodontic journal</journal><pubmed_title>A Thermosensitive Gel Containing Biodegradable Nanoparticles Carrying Calcium Hydroxide as Antibacterial Intracanal Therapy.</pubmed_title><pmcid>PMC12701751</pmcid><funding_grant_id>FBG 600324</funding_grant_id><funding_grant_id>PROD00141</funding_grant_id><funding_grant_id>2022 FISDU 00360</funding_grant_id><pubmed_authors>Espina M</pubmed_authors><pubmed_authors>Roig-Soriano X</pubmed_authors><pubmed_authors>Duran-Sindreu F</pubmed_authors><pubmed_authors>Teule M</pubmed_authors><pubmed_authors>Sanchez JAG</pubmed_authors><pubmed_authors>Sanchez-Lopez E</pubmed_authors><pubmed_authors>Garcia ML</pubmed_authors><pubmed_authors>Delgado LM</pubmed_authors><pubmed_authors>Elmsmari F</pubmed_authors><pubmed_authors>Esteruelas G</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Thermosensitive Gel Containing Biodegradable Nanoparticles Carrying Calcium Hydroxide as Antibacterial Intracanal Therapy.</name><description>&lt;h4>Aim&lt;/h4>To characterise and evaluate mucoadhesive strength and antibacterial properties of a nanotechnological formulation for endodontic disinfection based on biodegradable nanoparticles dispersed in a thermosensitive gel containing calcium hydroxide (Ca(OH)&lt;sub>2&lt;/sub>-NPs-gel).&lt;h4>Methodology&lt;/h4>Morphology of Ca(OH)&lt;sub>2&lt;/sub>-NPs-gel was studied using transmission electron microscopy. Moreover, Ca(OH)&lt;sub>2&lt;/sub>-NPs-gel was sterilised using gamma irradiation (25 kGy), and the stability after the sterilisation process was studied by measuring Ca(OH)&lt;sub>2&lt;/sub>-NPs-gel average size, polydispersity index, zeta potential and encapsulation efficiency. To assess the ex vivo mucoadhesive strength, extracted single-rooted human teeth were used to measure the force necessary to separate the formulation from the teeth. In addition, the short-time stability of Ca(OH)&lt;sub>2&lt;/sub>-NPs-gel was evaluated monthly, analysing entrapment efficacy, backscattering and transmittance of Ca(OH)&lt;sub>2&lt;/sub>-NPs-gel stored at different temperatures (4°C, 25°C and 37°C). Furthermore, the antibacterial analysis of Ca(OH)&lt;sub>2&lt;/sub>-NPs-gel was performed against Enterococcus faecalis inoculated in extracted human single-root teeth and evaluated by confocal and scanning electron microscopy. Finally, the metabolic activity of bacteria was studied through a resazurin assay to evaluate bacterial survival after treatment.&lt;h4>Results&lt;/h4>Ca(OH)&lt;sub>2&lt;/sub>-NPs-gel owned a round shape and a smooth surface without particle aggregation. Sterilisation did not induce an alteration in Ca(OH)&lt;sub>2&lt;/sub>-NPs-gel physicochemical properties and Ca(OH)&lt;sub>2&lt;/sub>-NPs-gel presented a high adhesion strength. In addition, 4°C was the best temperature to store Ca(OH)&lt;sub>2&lt;/sub>-NPs-gel. Regarding the antibacterial therapeutic efficacy, Ca(OH)&lt;sub>2&lt;/sub>-NPs-gel possesses suitable antibacterial properties, indicating that it efficiently reduces bacterial biofilms.&lt;h4>Conclusion&lt;/h4>Calcium hydroxide-loaded PLGA nanoparticles dispersed in a thermosensitive gel have been developed, optimised and characterised, obtaining excellent antibacterial properties and achieving bacterial disinfection levels similar to those of commercial formulations.</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-06-06T02:57:05.373Z</modification><creation>2026-05-24T03:13:05.836Z</creation></dates><accession>S-EPMC12701751</accession><cross_references><pubmed>41054854</pubmed><doi>10.1111/iej.70032</doi></cross_references></HashMap>